PAA 2.63% 19.5¢ pharmaust limited

Ann: Confirmation of Preliminary COVID-19 Results, page-163

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,412 Posts.
    lightbulb Created with Sketch. 1500
    The short answer is The world cannot wait and they've been trying to create a vaccine for Covids ugly sister SARS since the outbreak in 2003 and still haven't succeeded. This is not a flu virus. Anyway, safety trials and 2 decades of commercial use of MPL in farm animals as Zolvix to get rid of parasites (human food chain and all that) means there is a lot known from practical experience about safety. PAA also has already done the phase one human trial (for cancer) So safety is not a huge issue, especially for something that's going to be used for a short period. So moving to trials with animals and then to humans to see if it actually works clinically, could be done very quickly.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.